These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3191661

  • 1. Changes in coronary haemodynamics and myocardial metabolism at rest and during exercise after a cardiotonic drug (prenalterol) in patients with coronary artery disease.
    Westheim A, Bae E, Christensen CC, Fønstelien E, Grendahl H, Muller O.
    Clin Physiol; 1988 Oct; 8(5):463-74. PubMed ID: 3191661
    [Abstract] [Full Text] [Related]

  • 2. Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure.
    Kupper W, Schütt M, Bleifeld W.
    Acta Med Scand Suppl; 1982 Oct; 659():287-98. PubMed ID: 6127895
    [Abstract] [Full Text] [Related]

  • 3. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W, Schütt M, Hamm CW, Kuck KH, Hanrath P, Bleifeld W.
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC, Walton JA, Brymer JF, Beauman G, Pitt B.
    J Cardiovasc Pharmacol; 1984 Aug; 6(5):852-8. PubMed ID: 6209491
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of intravenously administered prenalterol in patients with severe heart failure.
    Waagstein F, Estrada-Yamamoto M, Reiz S, Reyes C, Hjalmarson A.
    Acta Med Scand Suppl; 1982 Aug; 659():221-31. PubMed ID: 6127891
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamic effects of prenalterol in patients with severe congestive heart failure--NYHA III-IV.
    Erbel R, Meyer J, Schweizer P, Lambertz H, Voelker W, Effert S.
    Acta Med Scand Suppl; 1982 Aug; 659():169-80. PubMed ID: 6127887
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock.
    Reiz S, Friedman A.
    Acta Anaesthesiol Scand; 1980 Aug; 24(1):5-10. PubMed ID: 7376804
    [Abstract] [Full Text] [Related]

  • 8. Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease.
    Thomassen A, Nielsen TT, Bagger JP, Henningsen P.
    Diabetes; 1989 Sep; 38(9):1175-80. PubMed ID: 2670646
    [Abstract] [Full Text] [Related]

  • 9. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ, Kelly MJ, Middlebrook K, Federman J, Sainsbury E, Ashley J, Pitt A.
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [Abstract] [Full Text] [Related]

  • 10. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC, Murray RG, Pearson D, Martin W, Hutton I.
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [Abstract] [Full Text] [Related]

  • 11. Contractile, coronary, and metabolic effects of the acute and long-term treatment of cardiac failure with prenalterol.
    Strauer BE, Bohn I, Hahn B, Kment A, Motz U.
    J Cardiovasc Pharmacol; 1984 Apr; 6(3):491-8. PubMed ID: 6202977
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
    Thormann J, Kramer W, Schlepper M.
    Am Heart J; 1982 Dec; 104(6):1294-302. PubMed ID: 7148647
    [Abstract] [Full Text] [Related]

  • 13. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W, Wauer B, Isbary J.
    Acta Med Scand Suppl; 1982 Dec; 659():307-14. PubMed ID: 6127897
    [Abstract] [Full Text] [Related]

  • 14. Effects of prenalterol on central hemodynamics and myocardial metabolism in experimental propoxyphene-induced shock.
    Häggmark S, Strøm J, Reiz S, Nyhman H, Angelo H, Sloth Madsen P, Bredgaard Sørensen M.
    Acta Anaesthesiol Scand; 1987 Jan; 31(1):52-6. PubMed ID: 3825476
    [Abstract] [Full Text] [Related]

  • 15. Haemodynamic effects of prenalterol in acute myocardial ischaemia in open chest pigs.
    Branzi A, Binetti G, Specchia S, Magelli C, Zannoli R, Magnani B.
    Clin Exp Pharmacol Physiol; 1983 Jan; 10(3):219-27. PubMed ID: 6627738
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
    Dagenais GR, Moisan A, Marquis Y, Davies RO, Blouin S.
    Cardiovasc Res; 1976 Jan; 10(1):25-36. PubMed ID: 1253193
    [Abstract] [Full Text] [Related]

  • 19. Regulation of myocardial blood flow by oxygen consumption is maintained in the failing heart during exercise.
    Traverse JH, Melchert P, Pierpont GL, Jones B, Crampton M, Bache RJ.
    Circ Res; 1999 Mar 05; 84(4):401-8. PubMed ID: 10066674
    [Abstract] [Full Text] [Related]

  • 20. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA, Needham KE, Evenson MK, Win A, Mason DT.
    Am Heart J; 1981 Feb 05; 101(2):158-61. PubMed ID: 7468416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.